Delivery Order SPE2DB22D3501-SPE2DB25FXA38
Award Date 8/25/25
Potential Completion Date 8/26/25
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,135.02 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Liraglutide 3-Pak 18 mg/3 ml medication. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating it was competitively awarded through open procurement processes. This delivery order...
- This is a $4,341.11 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a diabetes treatment medication. The contract has an ultimate completion date of June 10, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Liraglutide 2-Pak 18 mg/3 ml pharmaceutical product with a contract value of $1,709.20. This competitively awarded, firm fixed-price delivery order was executed on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,007.13, is for the delivery of Liraglutide 3-Pak 18 mg/3 ml 3 ml, a medication used for the treatment of diabetes. The contract is a firm fixed-price delivery order with a completion date of March 28, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,581.38 firm fixed-price delivery order is for the supply of Liraglutide 3-Pak 18 mg/3 ml 3 ml, a diabetes treatment medication. The contract has an ultimate completion date of May 14, 2025 and was awarded on May 13, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This is a $8,722.36 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Liraglutide 3-Pak 18 mg/3 ml 3 ml, a diabetes medication. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA, which provides comprehensive global pharmaceutical support to military healthcare programs. The contract is not...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,629.46, is for the delivery of Liraglutide 3-pak 18 mg/3 ml 3 ml, a diabetes medication. The contract has a firm fixed price and an ultimate completion date of July 18, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Liraglutide 3-pak 18 mg/3 ml 3 ml, a medication used to treat diabetes. The award has a ceiling value of $1,835.04 and a completion date of July 7, 2025. This is a firm fixed-price, non-set-aside contract, indicating open competition. AmerisourceBergen Drug Corp also...
- This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,069.26 contract is for the delivery of 4568495958 - LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a diabetes medication. The order has a completion date of June 10, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,093.04, is for the delivery of Liraglutide 3-Pak 18 mg/3 ml 3 ml medical supplies. The contract has a firm fixed price pricing type and an ultimate completion date of March 26, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...